Clinical Trial Update: Study of INCA 0186 in Subjects With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study of INCA 0186 in patients with advanced solid tumors, including squamous cell carcinoma of the head and neck, has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Malignancies
• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• INCA 0186

Snippet

Sponsor: Incyte Corporation | Conditions: Advanced Solid Tumors, Squamous Cell Carcinoma of the Head and Neck (SCCHN) | Phase 1 | Status: TERMINATED